EP4360707A3 — Compositions for treating spinal muscular atrophy
Assigned to F Hoffmann La Roche AG · Expires 2024-08-07 · 2y expired
What this patent protects
The present invention provides pharmaceutical compositions comprising a compound of formula (I)wherein A, R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> are as described herein, as well as pharmaceutically acceptable salts thereof. Further the …
USPTO Abstract
The present invention provides pharmaceutical compositions comprising a compound of formula (I)wherein A, R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
Drugs covered by this patent
- Evrysdi (RISDIPLAM) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.